CAS: 796073-69-3
All products are only used for scientific research, instead of human or animal experiments.
Cat. No.:HD00038
Formula:C38H54ClN3O10S
Mol. Weight:780.37
Purity:≥98%
Long Term Storage:Store in a tight container at -20℃.
Description:Tubulin depolymerization
Size | Price, EXW | Stock | Quantity | Add to Cart |
---|---|---|---|---|
10mg | $210.00 | In stock | - 1 + | |
25mg | $365.00 | In stock | - 1 + | |
50mg | $625.00 | In stock | - 1 + | |
100mg | $995.00 | In stock | - 1 + | |
1g | Inquiry | In stock | - 1 + |
DM4 is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody drug conjugate. It is a structural analogue of maytansine, is a new thiol-containing and potent maytansinoid. DM4 is a cytotoxic maytansinoid drug. It is synthesized in order to link maytansinoids to antibodies via disulfide bonds. Maytansinoids inhibit tubulin polymerization and microtubule assembly and enhance microtubule destabilization, so there is potent suppression of microtubule dynamics resulting in a mitotic block and subsequent apoptotic cell death.
[2] Coiffier B, Thieblemont C, de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, Morschhauser F, Navarro R, Le Gouill S, Haioun C, Houot R, Casasnovas O, Holte H, Lamy T, Broussais F, Payrard S, Hatteville L, Tilly H. A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. Br J Haematol. 2016 Jun;173(5):722-30. doi: 10.1111/bjh.13992. Epub 2016 Mar 24. PubMed PMID: 27010483.
[3] Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I. Mesothelin Immunotherapy for Cancer: Ready for Prime Time? J Clin Oncol. 2016 Dec;34(34):4171-4179. Epub 2016 Oct 31. PubMed PMID: 27863199.
You are the 1680979 th Visitor
Phone:0086-571-86907218
Email:hdcsales@huidacollection.cn
Copyright © 2021 HuiDaCollection 浙ICP备20008217号 Designed by Wanhu